Reduced nicotine cigarettes: Smoking behavior and biomarkers of exposure among smokers not intending to quit

Cancer Epidemiology Biomarkers and Prevention

Volumn 23, Issue 10, 2014, Pages 2032-2040

  Hammond, David ^a   O'Connor, Richard J ^b  

^a UNIVERSITY OF WATERLOO   (Canada)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 HYDROXYPYRENE; CARBON MONOXIDE; CIGARETTE SMOKE; COTININE; CREATININE; NICOTINE; TOBACCO SMOKE; 1-HYDROXYPYRENE; BIOLOGICAL MARKER; PYRENE DERIVATIVE;

ADULT; AGED; ARTICLE; EXHALATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; QUESTIONNAIRE; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; CHEMISTRY; CLINICAL TRIAL; HEALTH BEHAVIOR; MIDDLE AGED; YOUNG ADULT;

ADULT; BIOLOGICAL MARKERS; CARBON MONOXIDE; COTININE; CREATININE; FEMALE; HEALTH BEHAVIOR; HUMANS; MALE; MIDDLE AGED; NICOTINE; PYRENES; SMOKING; TOBACCO; TOBACCO PRODUCTS; YOUNG ADULT;

EID: 84907481825     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0957     Document Type: Article

References (61)

1. Rose JE. Nicotine and nonnicotine factors in cigarette addiction. Psychopharmacology 2006;184:274-85.
2. Hoffmann D, Djordjevic MV, Brunnemann KD. Changes in cigarette design and composition over time and how they influence the yields of smoke constituents. In: The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of U.S. cigarettes. Report of the NCI Expert Committee. Smoking and Tobacco ControlMonograph No. 1. U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, NIH Publication No. 96-4028;1996. p. 15-37
3. U.S. Department of Health andHuman Services. Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Services, National Institutes of Health; National Cancer Institute, 2001.
4. Hurt RD, Robertson CR. Prying open the door to the tobacco industry's secrets about nicotine: the Minnesota Tobacco Trial. JAMA 1998; 280:1173-81.
5. Pankow JF, Tavakoli AD, Luo W, Isabelle LM. Percent free base nicotine in the tobacco smoke particulate matter of selected commercial and reference cigarettes. Chem Res Toxicol 2003;16:1014-8.
6. Wayne GF, Connolly GN, Henningfield JE. Assessing internal tobacco industry knowledge of the neurobiology of tobacco dependence. Nicotine Tob Res 2004;6:927-40.
7. Hammond D, O'Connor RJ. Chemical constituents and smoke emissions from Canadian cigarettes. Tob Control 2008;17:i24-i31.
8. Kozlowski LT, Mehta NY, Sweeney CT, Schwartz SS, Vogler GP, Jarvis MJ, et al. Filter ventilation and nicotine content of tobacco in cigarettes from Canada, the United Kingdom, and the United States. Tob Control 1998;7:369-75.
9. Kozlowski LT, O'Connor RJ. Cigarette filter ventilation is a defective design because of misleading taste, bigger, puffs, and blocked vents. Tob Control 2002;11:i40-i50.
10. Smoking and tobacco control monograph No. 1. National Cancer Institute (U.S.). The FTC cigarette test method for determining tar, nicotine, and carbon monoxide yields of US cigarettes: report of the NCI Expert Committee Bethesda, Maryland: National Institutes of Health (NIH Publication No 96-4028;1996. p. 151-60
11. Rose JE, BehmFM,Westman EC,ColemanRE. Arterial nicotine kinetics during cigarettesmoking and intravenous nicotineadministration:Implications for addiction. Drug Alcohol Depend 1999;56:99-107.
12. Benowitz NL, Jacob P III, Herrera B. Nicotine intake and dose response when smoking reduced-nicotine content cigarettes. Clin Pharmacol Ther 2006;80:703-14.
13. Pickworth WB, Fant RV, Nelson RA, Rohrer MS, Henningfield JE. Pharmacodynamic effects of new de-nicotinized cigarettes. Nicotine Tob Res 1999;1:357-64.
14. Robinson JH, Pritchard WS,Davis RA. Psyehopharmacological effects of smoking a cigarette with typical 'tar' and carbon monoxide yields but minimal nicotine. Psychopharmacology 1992;108:466-72.
15. Hasenfratz M, Baldinger B, Bittig K. Nicotine or tar titration in cigarette smoking behavior? Psychopharmacology 1993;112:253-8.
16. Rose JE, Behm FM. There is more to smoking than the CNS effects of nicotine. In: Adlkofer F, Thurau K, eds. Effects of Nicotine on Biological Systems 11, Adv Phar SC. Basel: Birkhauser; 1999, p. 239-46.
17. Buchhalter AR, Acosta MC, Evans SE, Breland AB, Eissenberg T. Tobacco abstinence symptom suppression: the role played by the smoking-related stimuli that are delivered by denicotinized cigarettes. Addiction 2005;100:550-9.
18. Butschky MF, Bailey D, Henningfield JE, Pickworth WB. Smoking without nicotine delivery decreases withdrawal in 12-hour abstinent smokers. Pharmacol Biochem Behav 1995;50:91-6.
19. Gross J, Lee J, Stitzer ML. Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal. Pharmacol Biochem Behav 1997;57:159-65.
20. Baldinger B, Hasenfratz M, Baittig K. Effects of smoking abstinence and nicotine abstinence on heart rate, activity and cigarette craving under field conditions. Hum Psychopharm 1995;10:127-36.
21. Brauer LH, Behm FM, Lane JD, Westman EC, Perkins C, Rose JE. Individual differences in smoking reward from denicotinized cigarettes. Nicotine Tob Res 2001;3:101-9.
22. Rose JE, Westman EC, Behm FM. The use of denicotinized cigarettes to reduce tobacco dependence. Poster presentation at the annual meeting of the Society for Research on Nicotine and Tobacco, Seattle, WA. 2001.
23. Barret SP, Darredeau C. The acute effects of nicotine on the subjective and behavioural responses to denicotinized tobacco in dependent smokers. Behav Pharmacol 2012;23:221-7.
24. Rose JE, Levin ED. Inter-relationships between conditioned and primary reinforcement in the maintenance of cigarette smoking. Br J Addict 1991;86:605-9.
25. Dunsby J, Bero L. A nicotine delivery device without the nicotine? Tobacco industry development of low nicotine cigarettes. Tob Control 2004;13:362-9.
26. Benowitz NL, Henningfield JE. Reducing the nicotine content to make cigarettes less addictive. Tob Control 2013;22 Suppl 1:i14-7.
27. Institute of Medicine. Ending the tobacco problem: a blueprint for the nation. Washington, DC: The National Academies Press; 2007.
28. Benowitz N. Compensatory smoking of low-yield cigarettes. In: Risks associated with smoking cigarettes with low machine-measured yields of tar and nicotine. U.S. Department of Health and Human Services. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Services, National Institutes of Health; National Cancer Institute; 2001. p. 39-63.
29. Hammond D, Fong GT, Cummings KM, Hyland A. Smoking topography, brand switching, and nicotine delivery: an in vivo trial. Cancer Epidemiol Biomarkers Prev 2004;14:1-6.
30. Hammond D, Collishaw N, Callard C. Tobacco industry research on smoking behaviour and product design. Lancet 2006;367:781-7.
31. Jarvis MJ, Boreham R, Primatesta P, Feyerabend C, Bryant A. Nicotine yield from machine smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey. J Natl Cancer Inst 2001;93:134-8.
32. Hecht SS, Murphy SE, Carmella SG, Li S, Jensen J, Le C, et al. Similar uptake of lung carcinogens by smokers of regular, light, and ultralight cigarettes. Cancer Epidemiol Biomarkers Prev 2005;14:693-8.
33. Philip Morris (New Zealand) Ltd and Philip Morris International Managent SA's. Joint Comments on Smoke-free Environments regulations: Consultation Document. October, 2004. [Accessed 2013May 5]. Available from: http://www.philipmorrisinternational.com/global/ downloads/OBE/NZ-Comments-on-SFE-Regulations.pdf.
34. Rose JE, Behm FM. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob Res 2004;6:523-32.
35. Kassel JD, Greenstein JE, Evatt DP, Wardle MC, Yates MC, Veilleux JC, et al. Smoking topography in response to denicotinized and highyield nicotine cigarettes in adolescent smokers. J Adolesc Health 2007;40:54-60.
36. StrasserAA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA.New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure. Drug Alcohol Depend 2007;86: 294-300.
37. Rose J, Behm FM. Effects of low nicotine content cigarettes on smoke intake. Nicotine Tob Res 2004;6:309-19.
38. Donny EC, Houtsmuller E, Stitzer ML. Smoking in the absence of nicotine: behavioral, subjective and physiological effects over 11 days. Addiction 2007;102:324-34.
39. Benowitz NL, Dians KM, Hall SM, Stewart S, Wilson M, et al., Nicotine and carcinogen exposure with smoking of progressively reducednicotine content cigarette. Cancer Epidemiol Biomarkers Prev 2007; 16:2479-85.
40. Benowitz NL, Dains KM, Hall SM, Stewart S, Wilson M, Dempsey D, et al. Smoking behavior and exposure to tobacco toxicants during 6 months of smoking progressively reduced nicotine content cigarettes. Cancer Epidemiol Biomarkers Prev 2012;21:761-9.
41. Hatsukami DK, Kotlyar M, Hertsgaard LA, Zhang Y, Carmella SG, Jensen JA, et al. Reduced nicotine content cigarettes: effects on toxicant exposure, dependence and cessation. Addiction 2010;105: 343-55.
42. Hatsukami DK, Hertsgaard LA, Vogel RI, Jensen JA, Murphy SE, Hecht SS. Reduced nicotine content cigarettes and nicotine patch. Cancer Epidemiol Biomarkers Prev 2013;2:1015-24.
43. Hatsukami DK, Heishman SJ, Vogel RI, Denlinger RL, Roper-Batker AN, Mackowick KM, et al. Dose-response effects of spectrum research cigarettes. Nicotine Tob Res 2013;15:1113-21.
44. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991;86:1119-27.
45. Shiffman S, Waters A, Hickcox M. The Nicotine Dependence Syndrome Scale: a multidimensional measure of nicotine dependence. Nicotine Too Res 2004;6:327-48.
46. Cox LS, Tiffany ST, Christen AG. Evaluation of the Brief Questionnaire of Smoking Urges (QSU-Brief) in laboratory and clinical settings. Nicotine Tob Res 2001;3:7-16.
47. Toll BA, KatulakNA,McKee SA. Investigating the factor structure of the Questionnaire on Smoking Urges-Brief (QSU-Brief). Addict Behav 2006;31:1231-9.
48. Shahab L, Hammond D, O'Connor RJ, Michael Cummings K, Borland R, King B, et al. The reliability and validity of self-reported puffing behavior: evidence from a cross-national study. Nicotine Tob Res 2008;10:867-74.
49. Hatsukami DK, Hecht SS, Hennrikus DJ, Joseph AM, Pentel PR. Biomarkers of tobacco exposure or harm: Application to clinical and epidemiological studies-conference Summary. Nic Tob Res 2003; 5:387-96.
50. Meger M, Meger-Kossien I, Schuler-Metz A, Janket D, Scherer G. Simultaneous determination of nicotine and eight nicotine metabolites in urine of smokers using liquid chromatography-tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2002; 778:251-61.
51. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis 2002;23:907-22.
52. Romanoff LC, Li Z, Young KJ, BlakelyNC3rd, PattersonDGJr, Sandau CD. Automated solid-phase extraction method for measuring urinary polycyclic aromatic hydrocarbon metabolites in human biomonitoring using isotope-dilution gas chromatography high-resolution mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2006; 835:47-54.
53. Barr DB, Wilder LC, Caudill SP, Gonzales AJ, Needham LL, Pirkle JL. Urinary creatinine concentrations in the U.S. population: implications for urinary biologic monitoring measurements. Environ Health Perspect 2005;113:192-200.
54. Vine MF, Hulka BS, Margolin BH, Truong YK, Hu PC, Schramm MM, et al. Cotinine concentrations in semen, urine and blood of smokers and nonsmokers. Am J Public Health 1993;83:1335-8.
55. Hammond D, O'Connor RJ. Reduced nicotine content cigarettes: Smoking behaviour, biomarkers of exposure and product perceptions. Oral presentation at the annual meeting of the Society for Research on Nicotine and Tobacco, Boston, MA. 2013.
56. Macqueen DA, Heckman BW, Blank MD, Janse Van Rensburg K, Evans DE, Drobes DJ. Transient compensatory smoking in response to placebo cigarettes. Psychopharmacology (Berl) 2012; 223:47-54.
57. Tiffany ST, Drobes DJ. The development and initial validation of a questionnaire on smoking urges. Brit J Addict 1991;86: 1467-76.
58. Heishman SJ, Taylor RC, Henningfield JE. Nicotine and smoking: a review of effects on human performance. Exp Clin Psychopharm 1994;2:345-95.
59. Hughes JR, Hatsukami DK. Signs and symptoms of tobacco withdrawal. Arch General Psychiat 1986;43:289-94.
60. Shiffman SM, Jarvik ME. Smoking withdrawal symptoms in two weeks of abstinence. Psychopharmacology 1976;50:35-9.
61. NIDA. Notice of availability of nicotine research cigarettes through NIDA's drug supply program. [cited 2012 October 5]. Available from: http://grants.nih.gov/grants/guide/notice-files/NOT-DA-13-002.html.